Skip to main content
Bloomberg Logo
Bloomberg

Articles by Bloomberg

Bloomberg

Apple-OpenAI Alliance Frays

Apple Inc.'s two-year-old partnership with OpenAI has become strained, according to people familiar with the matter, with the AI startup failing to see the expected benefits from the deal and now preparing possible legal action.  Anurag Rana, Bloomberg Intelligence Technology Analyst, joins to discuss.

Read more
Bloomberg

Inside Paul Tudor Jones' Sports AI Startup

SumerSports, a startup founded by Paul Tudor Jones, is trying to transform football using artificial intelligence. SūmerSports CEO Lorrissa Horton joined Bloomberg Open Interest to explain how NFL teams are using frame-by-frame AI tracking for scouting, player development, predictive play analysis, and fan engagement. It's all powered by hedge-fund style analytics that was originally inspired by fantasy football.

Read more
Bloomberg

Cerebras Pulls Back After IPO Day; Gemini Space Station Rises on $100M Investment | Stock Movers

On this episode of Stock Movers with Alexis Christoforous: - Gemini Space Station (GEMI) is rising after Tyler and Cameron Winklevoss made a $100 million "strategic investment" into the company. CEO Tyler Winklevoss said the investment will help fuel the company's ambition to evolve from a crypto company into a markets company. - Magnum Ice Cream (MICC) shares are jumped as much as 22%, the most since the stock's December listing, after Reuters reported that private equity firms including Blackstone and Clayton Dubilier & Rice are exploring potential bids for the company. - Cerebras Systems (CBRS) shares pulled back after a huge IPO day yesterday. The shares jumped 68% in its trading debut after raising $5.5 billion in the year's largest IPO.

Read more
Bloomberg

Dexcom's Bet Beyond Diabetes

Dexcom CEO Jake Leach joined Bloomberg Open Interest to explain why continuous glucose monitors are becoming much bigger than diabetes devices. He says GLP-1 drugs are actually boosting CGM adoption and defends the company's growth outlook. He also lays out Dexcom's push into mainstream metabolic health and wellness.

Read more